NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹285 Cr | ₹243 Cr | ₹249 Cr | ₹178 Cr | ₹13,192,719 Cr |
What is the latest Total Expenditure of NGL FINECHEM ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹285 Cr |
| Mar2024 | ₹243 Cr |
| Mar2023 | ₹249 Cr |
| Mar2022 | ₹178 Cr |
| Mar2021 | ₹13,192,719 Cr |
How is Total Expenditure of NGL FINECHEM Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹285 Cr | 17.20 | |
| Mar2024 | ₹243 Cr | -2.48 | |
| Mar2023 | ₹249 Cr | 40.17 | |
| Mar2022 | ₹178 Cr | -100.00 | |
| Mar2021 | ₹13,192,719 Cr | - | |
Compare Total Expenditure of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹944.7 Cr | 5.5% | 15.7% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 5.5% |
15.7% |
-12.8% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses